Oncobiologics’ (OTLK) Neutral Rating Reaffirmed at HC Wainwright

Oncobiologics (NASDAQ:OTLK – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at HC Wainwright in a research note issued to investors on Friday, MarketBeat reports. Other equities research analysts also recently issued reports ab…

Read Full Article →